US Patent 7994279 Altered peptide ligands of GAD65
Patent 7994279 was granted and assigned to The University Of Toledo on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+305 characters)
Article
Patent abstract
Modified GAD65 compositions antagonize the activities of islet-specific T cells that contribute to the progression of one or more autoimmune disorders. The compositions are also antagonistic in humanized mice that express human HLA alleles associated with increased-risk of Type 1 diabetes.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Anthony Quinn0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07994279 Altered peptide ligands of GAD65 US Patent 7994279 Altered peptide ligands of GAD65
Infobox
Patent Number
079942790
Patent Number
79942790
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079942790
Date of Patent
August 9, 2011
0Patent Application Number
122957930
Date Filed
March 30, 2007
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07994279 Altered peptide ligands of GAD65
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07994279
Date of patent
August 9, 2011
Patent application number
12295793
Date Filed
March 30, 2007
Patent primary examiner
Find more entities like US Patent 7994279 Altered peptide ligands of GAD65
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
